As I wrote in May 2021, when the BIC/FIC was clear and other developing FTO inhibitors were first coming out in articles; it doesn't matter if they prove another FTO inhibitor in the clinic ... we'll instantly be snapped up as a clinically proven inhibitor for orders of magnitude more than our current market cap.
You're right, the opportunities are now so large! Cardioprotection and now independent radiotherapy have been added since May 2021; each being massive company makers imho.
It's time to come out and explode!
RAC Price at posting:
$2.20 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)